Development of extracellular vesicle therapeutics: Challenges, considerations, and opportunities
B Claridge, J Lozano, QH Poh… - Frontiers in Cell and …, 2021 - frontiersin.org
Extracellular vesicles (EVs) hold great promise as therapeutic modalities due to their
endogenous characteristics, however, further bioengineering refinement is required to …
endogenous characteristics, however, further bioengineering refinement is required to …
Bacterial outer membrane vesicles as a platform for biomedical applications: An update
Outer membrane vesicles (OMVs) are produced by Gram-negative bacteria both in vitro and
in vivo. OMVs are nano-sized spherical vehicles formed by lipid bilayer membranes and …
in vivo. OMVs are nano-sized spherical vehicles formed by lipid bilayer membranes and …
Bacterial membrane vesicles for vaccine applications
Vaccines have been highly successful in the management of many diseases. However,
there are still numerous illnesses, both infectious and noncommunicable, for which there are …
there are still numerous illnesses, both infectious and noncommunicable, for which there are …
The power of asymmetry: architecture and assembly of the Gram-negative outer membrane lipid bilayer
JC Henderson, SM Zimmerman… - Annual review of …, 2016 - annualreviews.org
Determining the chemical composition of biological materials is paramount to the study of
natural phenomena. Here, we describe the composition of model gram-negative outer …
natural phenomena. Here, we describe the composition of model gram-negative outer …
Engineered bacterial extracellular vesicles for central nervous system diseases
N Ji, F Wang, M Wang, W Zhang, H Liu, J Su - Journal of Controlled …, 2023 - Elsevier
The prevalence of central nervous system (CNS) diseases is on the rise as the population
ages. The presence of various obstacles, particularly the blood-brain barrier (BBB), poses a …
ages. The presence of various obstacles, particularly the blood-brain barrier (BBB), poses a …
Outer membrane vesicles displaying engineered glycotopes elicit protective antibodies
The O-antigen polysaccharide (O-PS) component of lipopolysaccharides on the surface of
gram-negative bacteria is both a virulence factor and a B-cell antigen. Antibodies elicited by …
gram-negative bacteria is both a virulence factor and a B-cell antigen. Antibodies elicited by …
A role for extracellular vesicles in SARS-CoV-2 therapeutics and prevention
Extracellular vesicles (EVs) are the common designation for ectosomes, microparticles and
microvesicles serving dominant roles in intercellular communication. Both viable and dying …
microvesicles serving dominant roles in intercellular communication. Both viable and dying …
Glycoengineering bioconjugate vaccines, therapeutics, and diagnostics in E. coli
CM Harding, MF Feldman - Glycobiology, 2019 - academic.oup.com
The first, general glycosylation pathway in bacteria, the N-linked glycosylation system of
Campylobacter jejuni, was discovered two decades ago. Since then, many diverse …
Campylobacter jejuni, was discovered two decades ago. Since then, many diverse …
Role of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal disease
LK McNeil, RJ Zagursky, SL Lin, E Murphy… - Microbiology and …, 2013 - Am Soc Microbiol
Neisseria meningitidis is a Gram-negative microorganism that exists exclusively in humans
and can cause devastating invasive disease. Although capsular polysaccharide-based …
and can cause devastating invasive disease. Although capsular polysaccharide-based …
Phylogenetic classification and functional review of autotransporters
Autotransporters are the core component of a molecular nano-machine that delivers cargo
proteins across the outer membrane of Gram-negative bacteria. Part of the type V secretion …
proteins across the outer membrane of Gram-negative bacteria. Part of the type V secretion …